Genenta Science SPA (GNTA) FinancialsGNTAGenenta Science SPA

Evaluating the bottom line, Genenta Science SpA maintains a gross margin of N/A. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at N/A, while the net margin is N/A. These profitability ratios, combined with a Return on Equity (ROE) of -60.15%, provide a clear picture of how effectively GNTA converts its operational activities into shareholder value.

In the context of the broader market, GNTA competes directly with industry leaders such as VTSI and UAVS. With a market capitalization of $47.50M, it holds a leading position in the sector. When comparing efficiency, GNTA's gross margin of N/A stands against VTSI's 59.27% and UAVS's 50.63%. Such benchmarking helps identify whether Genenta Science SpA is trading at a premium or discount relative to its financial performance.

The company's total equity increased from 12,114,140 EUR in Q3 2025 to 21,840,640 EUR in Q1 2026, showing a strong financial position. Current assets also rose from 20,995,066 EUR to 29,979,552 EUR in the same period, indicating improved liquidity.